WARFARIN RESISTANCE

被引:40
作者
LEWIS, RJ
SPIVACK, M
SPAET, TH
机构
关键词
D O I
10.1016/0002-9343(67)90061-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:620 / &
相关论文
共 49 条
[1]  
AGGELER PM, 1966, PATHOGENESIS TREATME, P227
[2]   CLINICAL EXPERIENCE WITH ANTICOAGULANT PANWARFIN (WARFARIN SODIUM) [J].
ARAVANIS, C ;
MICHAELIDES, G ;
EVANGELOU, I .
ANGIOLOGY, 1963, 14 (06) :325-&
[3]  
AVELLANEDA M, 1955, Medicina (B Aires), V15, P109
[4]  
Baumann CA, 1942, J BIOL CHEM, V146, P7
[5]  
BOYLES PW, 1959, ANTITHROMBOTIC THERA, P25
[6]  
BRODIE B B, 1959, Med Exp Int J Exp Med, V1, P290
[7]  
BRODIE BB, 1965, DRUGS ENZYMES ED, V4, P9
[8]  
CATALANO PM, 1966, CLIN RES, V14, P266
[9]   ANTAGONISTIC EFFECT OF ACTH AND CORTISONE ON THE ANTICOAGULANT ACTIVITY OF ETHYL BISCOUMACETATE [J].
CHATTERJEA, JB ;
SALOMON, L .
BRITISH MEDICAL JOURNAL, 1954, 2 (4891) :790-792
[10]   SPECIFIC ASSAY OF PROWER-STUART FACTOR AND FACTOR VII [J].
DENSON, KW .
ACTA HAEMATOLOGICA, 1961, 25 (02) :105-&